4//SEC Filing
Higgins Jack 4
Accession 0001415889-24-021656
CIK 0001472012other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 9:05 PM ET
Size
10.4 KB
Accession
0001415889-24-021656
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Higgins Jack
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-08-15$13.93/sh−3,524$49,072→ 16,000 total - Exercise/Conversion
Common Stock
2024-08-15$1.35/sh+19,524$26,357→ 19,524 total - Gift
Common Stock
2024-08-19−2,471→ 13,529 total - Exercise/Conversion
Stock option (right to buy)
2024-08-15−19,524→ 179,040 totalExercise: $1.35Exp: 2032-06-23→ Common Stock (19,524 underlying)
Footnotes (3)
- [F1]The shares were sold pursuant to sell to cover transactions.
- [F2]The weighted average sale price for the transaction report was $13.925, and the range of prices were between $13.800 and $14.020. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F3]25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001993684
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 9:05 PM ET
- Size
- 10.4 KB